Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
accesspharma.com

See what CB Insights has to offer

Founded Year

1988

Stage

PIPE - II | IPO

Total Raised

$9.66M

About Access Pharmaceuticals

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access Pharmaceuticals' investors include SDS Capital Partners, Weiss Peck & Greer Investments, Hudson Bay Capital Management, Close Investments Global Investment Funds, Atoll Asset Management, AS Capital Partners, Downsview Capital, Viking Capital, DKR Saturn Management, Balyasny Asset Management, Midsummer Capital, Alpha Capital Partners, BayStar Capital and Consulta.

Access Pharmaceuticals Headquarter Location

2600 Stemmons Freeway Suite 176

Dallas, Texas, 75207,

United States

214-905-5100

Latest Access Pharmaceuticals News

Oral Mucositis Drugs Market Expectations, Industry Size, Share, Trends, Revenue, Demand and Growth Factors Highlighted to 2027 by AMAG Pharmaceuticals, Access Pharmaceuticals, DARA BioSciences, Helsinn Group

Dec 17, 2020

Search jobs 17-Dec-2020 Oral Mucositis Drugs Market Expectations, Industry Size, Share, Trends, Revenue, Demand and Growth Factors Highlighted to 2027 by AMAG Pharmaceuticals, Access Pharmaceuticals, DARA BioSciences, Helsinn Group A recent market research report entitled Global Oral Mucositis Drugs Market Size, Share, Growth, Industry Trends, and Forecast to 2027 done by our research team depicts the comprehensive and collaborative analysis of industry during past, present, and forecast periods. The report determines historic growth analysis and current scenario of global Oral Mucositis Drugs industry market place and intends to offer actionable insights on global market growth projections. The report sheds light on all the industry verticals like competitive market scenario, regional presence, and development opportunities. The next part covers the market competition landscape based on revenue and growth rate. Further, it explains market types, applications, and price analysis. Download Free Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-oral-mucositis-drugs-market Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above mentioned forecast period. Emerging markets and huge investments in research and development are the factors responsible for the growth of this market. Growing cases of head and neck cancers worldwide drives the oral mucositis drugs market. Due to increased mouth & oral cavity infections, bad oral hygiene and poor lifestyle also boost up the oral mucositis drugs market growth. However, increased and continuous advancement in technology for the diagnosis & treatment is also boosting the market growth. But, specific drugs treatment not available for the infection or disease and high cost of the treatment which may hamper the global oral mucositis drugs market. Oral mucositis is the most common symptom of debilitating complication of cancer treatments, which break down the rapidly divided epithelial cells lining the gastro-intestinal tract (which goes from the mouth to the anus), leaving the mucosal tissue open to ulceration and infection. Oral mucositis majorly occurs due to chemotherapy and radiotherapy. This disorder can lead to the sever health problems such as blood in the mouth, sores in the mouth (gums & tongue), soreness in mouth & throat, feeling of dryness, mild burning, or pain when eating food and others. The Global Oral Mucositis Drugs Market 2020 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Oral Mucositis Drugs Market Share analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. For each manufacturer covered, this report analyzes their Oral Mucositis Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market. According to this report Global Oral Mucositis Drugs Market will rise from Covid-19 crisis at moderate growth rate during 2020 to 2027. Oral Mucositis Drugs Market includes comprehensive information derived from depth study on Oral Mucositis Drugs Industry historical and forecast market data. Global Oral Mucositis Drugs Market Size To Expand moderately as the new developments in Oral Mucositis Drugs and Impact of COVID19 over the forecast period 2020 to 2027. To Understand How Covid-19 Impact Is Covered In This Report, Get Free Covid-19 Sample @ https://www.databridgemarketresearch.com/toc/?dbmr=global-oral-mucositis-drugs-market Oral Mucositis Drugs Market report provides depth analysis of the market impact and new opportunities created by the COVID19/CORONA Virus pandemic. Report covers Oral Mucositis Drugs Market report is helpful for strategists, marketers and senior management, And Key Players in Oral Mucositis Drugs Industry. Associated side effects of the drugs are expected to impede the market growth List of TOP KEY PLAYERS in Oral Mucositis Drugs Market Report are – ·         AMAG Pharmaceuticals, Inc ·         ….. Complete Report is Available (Including Full TOC, List of Tables & Figures, Graphs, and Chart) @ https://www.databridgemarketresearch.com/toc/?dbmr=global-oral-mucositis-drugs-market The report also focuses on global major leading industry players of Global Oral Mucositis Drugs Market Share providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. Competitive analysis performed in this report puts forth the moves of the key players in the Oral Mucositis Drugs industry such as new product launches, expansions, agreements, joint ventures, partnerships, and recent acquisitions. All the data, statistics, and information gathered to generate this report has been studied and analyzed with the established tools and techniques such as SWOT analysis and Porter’s Five Forces analysis. On geographically estimation, North America accounts the largest market share due to increased healthcare and R&D expenditure and presence of skilled professionals. Europe is considered second largest market for oral mucositis drugs due to advancement in technology and increased prevalence of oral cancer infections. Asia-Pacific is expected to account for the largest market share over coming years for the market due to increased head and neck diseases, increased awareness for through advertisement & media and rapidly improving health care infrastructure in the region. Highlights of the Report: ·         In-depth analysis of the growth drivers and obstacles. ·         Profile of all the companies operating in the market. ·         Elaborate data about the dominating region. ·         Competitive landscape consisting of mergers & acquisitions, investments, partnerships, new product launches, opening of new facilities, and new contracts. The Segments and Sub-Section of Oral Mucositis Drugs Market are shown below: By Causes ( Chemotherapy-Induced, Radiotherapy-Induced, Others) by Drugs Class ( Antibiotics, Antifungal, Anti-Inflammatory, Anti-Neoplastic, Others) by Drugs  ( Gelclair, Zilactin, Ethyol, Morphine, MuGard, Others) by Dosage Form ( Ointment, Solution, Gel, Paints, Others) by End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others) by Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc. Global Oral Mucositis Drugs Market Scope and Market Size The oral mucositis drugs market is segmented on the basis of causes, drugs class, drugs, dosage form, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. On the basis of causes, the oral mucositis drugs market is segmented into chemotherapy-induced, radiotherapy-induced and others. On the basis of drugs class, the oral mucositis drugs market is segmented into antibiotics, antifungal, anti-inflammatory, anti-neoplastic and others. On the basis of drugs, the oral mucositis drugs market is segmented into gelclair, zilactin, ethyol, MuGard, morphine, and others. On the basis of dosage form, the oral mucositis drugs market is segmented into ointment, solution, gel, paints and others. On the basis of end-users, the oral mucositis drugs market is segmented into hospitals, specialty clinics, home healthcare and others. On the basis of distribution channel, the oral mucositis drugs market is segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others. Data Sources & Methodology         The primary sources involve the industry experts from the Global Oral Mucositis Drugs Market including the management organizations, processing organizations, analytics service providers of the industry’s value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects. In the extensive primary research process undertaken for this study, the primary sources – Postal Surveys, telephone, Online & Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Company’s Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weightage. For More Information or Query or Customization Before Buying, Visit@ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-oral-mucositis-drugs-market KEY QUESTIONS ANSWERED: Study Explore COVID 19 Outbreak Impact Analysis ·         What should be entry strategies, countermeasures to economic impact, and marketing channels? ·         What are market dynamics? ·         What is economic impact on market? ·         What is market chain analysis by upstream raw materials and downstream industry? ·         What is industry considering capacity, production and production value? What will be the estimation of cost and profit? What will be market share, supply and consumption? What about import and export? ·         What is current market status? What’s market competition in this industry, both company, and country wise? What’s market analysis by taking applications and types in consideration? ·         What were capacity, production value, cost and profit? ·         Who are the global key players in this industry? What are their company profile, their product information, and contact information? ·         Which manufacturing technology is used, what are their company profile, their product information, and contact information? Access Complete Report of Latest Version Global Oral Mucositis Drugs Market Study with COVID-19 Impact Analysis @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-oral-mucositis-drugs-market Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market. With tables and figures helping analyses worldwide Global Oral Mucositis Drugs Market Forecast this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Strategic Points Covered in Table of Content of Global Oral Mucositis Drugs Market: Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Global Oral Mucositis Drugs market Chapter 2: Exclusive Summary – the basic information of the Global Oral Mucositis Drugs Market. Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Global Oral Mucositis Drugs Chapter 4: Presenting the Global Oral Mucositis Drugs Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis. Chapter 5: Displaying the by Type, End User and Region 2010-2020 Chapter 6: Evaluating the leading manufacturers of the Global Oral Mucositis Drugs market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions. Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source Finally, Global Oral Mucositis Drugs Market is a valuable source of guidance for individuals and companies. To Know More Details, Visit in Depth Study Report @ https://www.databridgemarketresearch.com/reports/global-oral-mucositis-drugs-market Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia. OUR OTHER REPORTS:- About Data Bridge Market Research, Private Ltd Data Bridge Market Research  Pvt  Ltd  is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market. Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve. We provide a variety of services such as market verified industry reports, technology trend analysis, Formative market research, strategic consulting, vendor analysis, production and demand analysis, consumer impact studies among many others. Contact Us                                                         UK: +44 208 089 1725 Hong Kong: +852 8192 7475

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Access Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Access Pharmaceuticals is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Access Pharmaceuticals Patents

Access Pharmaceuticals has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/15/2002

6/16/2009

Oral mucosal pathology, Dosage forms, Drug delivery devices, Conditions of the mucous membranes, Inflammations

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

2/15/2002

00/00/0000

Grant Date

6/16/2009

00/00/0000

Title

Subscribe to see more

Related Topics

Oral mucosal pathology, Dosage forms, Drug delivery devices, Conditions of the mucous membranes, Inflammations

Subscribe to see more

Status

Grant

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.